Oxidative and inflammatory pathways in Parkinson's disease.
about
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesProthrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic SystemDysregulation of glutathione homeostasis in neurodegenerative diseasesNeuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityDopamine and paraquat enhance α-synuclein-induced alterations in membrane conductanceGastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathwaysAntioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatumImpact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.Neuroprotective effects of cuscutae semen in a mouse model of Parkinson's disease.Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potentialResveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions.Abasic sites preferentially form at regions undergoing DNA replication.Physical activity and environmental enrichment regulate the generation of neural precursors in the adult mouse substantia nigra in a dopamine-dependent manner.PEP-1-HO-1 prevents MPTP-induced degeneration of dopaminergic neurons in a Parkinson's disease mouse model.Resveratrol confers protection against rotenone-induced neurotoxicity by modulating myeloperoxidase levels in glial cellsRotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis.BL-1023 improves behavior and neuronal survival in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated miceCorrelation between serum RANTES levels and the severity of Parkinson's disease.Rotenone directly induces BV2 cell activation via the p38 MAPK pathway.Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity.Dual functionality of myeloperoxidase in rotenone-exposed brain-resident immune cells.Neurobiology of vascular dementia.Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life.Mitochondrial therapeutics in Alzheimer's disease and Parkinson's diseaseNeuroprotective effects of Eucommia ulmoides Oliv. and its bioactive constituent work via ameliorating the ubiquitin-proteasome systemSomatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.NF-κB in Aging and DiseasePhysiological antioxidative network of the bilirubin system in aging and age-related diseases.Neuroprotective Effects of San-Huang-Xie-Xin-Tang in the MPP(+)/MPTP Models of Parkinson's Disease In Vitro and In VivoATM kinase inhibition in glial cells activates the innate immune response and causes neurodegeneration in Drosophila.Plasma Prolidase Activity and Oxidative Stress in Patients with Parkinson's DiseaseCoenzyme Q10 deficiency in patients with Parkinson's disease.Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase-1 and brain-derived neurotrophic factor.A 5-Year Follow-up Study on the Relationship between Obstructive Sleep Apnea and Parkinson Disease.NADPH oxidase 1 mediates α-synucleinopathy in Parkinson's disease.Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein.Role and mechanism of microglial activation in iron-induced selective and progressive dopaminergic neurodegeneration.Crosstalk between Ca2+ signaling and mitochondrial H2O2 is required for rotenone inhibition of mTOR signaling pathway leading to neuronal apoptosis.Neonatal systemic exposure to lipopolysaccharide enhances susceptibility of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life.Vitamin K2 suppresses rotenone-induced microglial activation in vitro
P2860
Q24289511-0155625B-6A25-41BB-B574-876FE578FE55Q26738336-C935392C-6DE3-4324-BE08-69DB02812639Q26822726-51463C64-2A4E-4C9C-9962-B46600CDD4CBQ27027973-FAC6599E-0A66-4C23-B90F-00BDA579D6DDQ28392011-0D41D7D2-508D-4EBA-AE28-16CBFB3CB09AQ28478996-802ACA3E-4D98-4A86-B903-8E1AC8FCF8BBQ28566901-595FC4A2-102D-4872-A0E5-B9FC57E11E5EQ33722420-B3AB9D35-7061-4BA7-BBBC-E5A14F2AAC56Q34032558-46FF567D-1CAF-46F2-8D65-59618F503625Q34110107-8F3171AB-5440-4DA5-B3CA-3F85E193CAEAQ34127988-27091E1E-E8A3-48ED-931C-C20F2CDA2DE8Q34378827-74380831-0D13-47DA-A4C8-CF7CE5D287BDQ34461436-A005B9F5-8D4F-4AE8-A69E-B3C351E80B69Q34667239-E2B3751B-A5ED-4DAB-8AEE-CCD0807749DCQ34673645-1897CC8B-267A-4963-8F35-B662FC31880AQ34760248-E35AB5B0-BA3E-4FF8-BAC2-1A883564D4BEQ34762041-28FA09FA-41BB-4417-A1E6-CDF3AAB683F3Q34813794-ABB1ECB3-47C1-48D9-9C52-D767AAAE506CQ34972939-B04D1ACC-F40B-416D-8ED4-BBC72695F1CEQ35162073-39D19BD9-5EE8-48BF-99E0-D61727DFD267Q35167895-15C274AC-A69F-4010-9465-6CA2E00FA1BBQ35176496-EC621AD9-AF96-47B6-9B0B-09781456AC95Q35255816-BD5F6681-37A4-4BC8-9B75-850D223DFD81Q35579334-444363E8-422B-4214-BCB6-CCFAC611C488Q35627045-000330F1-2950-4883-929A-17AC292FEC79Q35628403-42CA336A-AA22-4385-8E27-DCE3155BC7A6Q35806773-88C44A7A-28C9-4034-848F-2B21D15CEAA7Q35828459-CC4FEDAF-2EC5-41B1-9C81-56A8558CD805Q35830378-CAEEDA23-DDBA-4934-B4E1-EEEDB02BF8B3Q35837175-12700BCF-F648-4CCC-8E0F-8497C96FDC43Q35988121-D9437333-4244-4B9E-B9AB-F436548A66B5Q36003957-9A8FAEBE-45F7-4F1F-B01B-5E3D11195237Q36158998-A2CBB1FB-5DA3-4507-A387-5FC83D9B10ECQ36323283-7A69E1C1-8E8B-42CB-B81F-BA00841289BFQ36408665-F68A4C61-74EF-4A6E-8CC5-80A9EADE73DFQ36640417-A6EFD5FB-5B9F-4BF9-BF92-9A725012A366Q36931995-4EFCEFB5-4BFA-4EB3-A7BD-6EF70449A664Q36946559-524840F6-9FBD-4CC6-8382-E1473F02E997Q37182878-06F46E41-721E-4705-869F-E167A7CE90E7Q37254595-F37B64B3-3650-4565-8843-209D43B0949F
P2860
Oxidative and inflammatory pathways in Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oxidative and inflammatory pathways in Parkinson's disease.
@en
Oxidative and inflammatory pathways in Parkinson's disease.
@nl
type
label
Oxidative and inflammatory pathways in Parkinson's disease.
@en
Oxidative and inflammatory pathways in Parkinson's disease.
@nl
prefLabel
Oxidative and inflammatory pathways in Parkinson's disease.
@en
Oxidative and inflammatory pathways in Parkinson's disease.
@nl
P2093
P1476
Oxidative and inflammatory pathways in Parkinson's disease.
@en
P2093
Albert Y Sun
Grace Y Sun
Marilyn James-Kracke
Rebecca L Miller
P2888
P356
10.1007/S11064-008-9656-2
P577
2008-03-25T00:00:00Z